Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Multiple drugs

Lack of efficacy and off label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Martin CYP, et al. [Translated article] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel disease. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 47: T297-T299, No. 6, Dec 2023. Available from: URL: https://dx.doi.org/10.1016/j.farma.2023.09.005 Martin CYP, et al. [Translated article] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel disease. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 47: T297-T299, No. 6, Dec 2023. Available from: URL: https://dx.doi.org/10.1016/j.farma.2023.09.005
Metadaten
Titel
Multiple drugs
Lack of efficacy and off label use
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57726-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Aspirin/heparin

Case report

COVID-19-vaccine

Case report

Hydroxycarbamide

Case report

Imatinib